About the journal
Pulmonary Therapy is an open-access journal published by Adis, Springer Healthcare in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 5,950 EUR. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Adis, Springer Healthcare
- ISSN
- 2364-1754 · 2364-1746
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 5,950 EUR
- Articles in DOAJ
- 240
- Declared review time
- 6 weeks
- Declared peer-review model
- other
- Official website
- https://www.springer.com/journal/41030
Index listings
- DOAJ · 2016-09-12
- PUBMED · 2025-09-26
- Indexing
- DOAJ · PUBMED
- APC
- 5,950 EUR
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
240
Most recent article
last month
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
350
Last recorded publication year
2026
h-index
33
i10-index
101
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2016-09-12
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 96%
- ORCID iDs in current deposits
- 69%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101687144
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Asthma and respiratory diseases
- Asthma and respiratory diseases
- Asthma and respiratory diseases
- Inhalation and Respiratory Drug Delivery
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Inhalation and Respiratory Drug Delivery
Show all subjects (75)
- Inhalation and Respiratory Drug Delivery
- Respiratory and Cough-Related Research
- Respiratory and Cough-Related Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Respiratory Support and Mechanisms
- Respiratory Support and Mechanisms
- Cystic Fibrosis Research Advances
- Cystic Fibrosis Research Advances
- Cystic Fibrosis Research Advances
- Pulmonary Hypertension Research and Treatments
- Respiratory Support and Mechanisms
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Delphi Technique in Research
- Delphi Technique in Research
- Pulmonary Hypertension Research and Treatments
- Pulmonary Hypertension Research and Treatments
- Obstructive Sleep Apnea Research
- COVID-19 Clinical Research Studies
- Vascular Anomalies and Treatments
- Occupational exposure and asthma
- Pleural and Pulmonary Diseases
- Pleural and Pulmonary Diseases
- Pleural and Pulmonary Diseases
- Obstructive Sleep Apnea Research
- Occupational and environmental lung diseases
- SARS-CoV-2 and COVID-19 Research
- Obstructive Sleep Apnea Research
- Respiratory viral infections research
- Health Systems, Economic Evaluations, Quality of Life
- Sleep and related disorders
- Respiratory viral infections research
- COVID-19 Clinical Research Studies
- Neonatal Respiratory Health Research
- Pharmaceutical studies and practices
- Pneumonia and Respiratory Infections
- Neonatal Respiratory Health Research
- Heart Failure Treatment and Management
- COVID-19 Clinical Research Studies
- Heart Failure Treatment and Management
- Allergic Rhinitis and Sensitization
- Sarcoidosis and Beryllium Toxicity Research
- Sarcoidosis and Beryllium Toxicity Research
- Allergic Rhinitis and Sensitization
- Respiratory and Cough-Related Research
- Allergic Rhinitis and Sensitization
- Transplantation: Methods and Outcomes
- Respiratory viral infections research
- Tracheal and airway disorders
- Mechanical Circulatory Support Devices
- Mechanical Circulatory Support Devices
- Tracheal and airway disorders
- Sleep and related disorders
- Nosocomial Infections in ICU
- Medication Adherence and Compliance
- SARS-CoV-2 and COVID-19 Research
- Sleep and related disorders
- Pharmacological Effects and Assays
- Pharmacological Effects and Assays
- Nosocomial Infections in ICU
- Transplantation: Methods and Outcomes
- Pharmacy and Medical Practices
- Transplantation: Methods and Outcomes
- SARS-CoV-2 and COVID-19 Research
- Lung Cancer Treatments and Mutations
- Heart Failure Treatment and Management
- Lung Cancer Diagnosis and Treatment
Keywords (DOAJ)
- respiratory medicine
- pulmonary medicine
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ